|
3-hydroxy-N-[(Z)-[5-(2-nitrophenyl)furan-2-yl]methylideneamino]benzamide |
|
Brucella |
VirB type IV secretion system |
Preclinical (in vivo) |
Smith MA, et al. 2012. Chem Biol |
|
3-[(4-Methoxyanilino)carbonyl]-1,2,2-trimethylcyclopentanecarboxylic acid |
Depiction based on curated SMILES
CH
3
CH
3
HO
O
CH
3
CH
3
O
N
H
O
|
Brucella |
VirB type IV secretion system |
Preclinical (in vivo) |
Paschos A, et al. 2011. Infect Immun |
|
4-amino-N-[(Z)-[5-(3-chlorophenyl)furan-2-yl]methylideneamino]-1,2,5-oxadiazole-3-carboxamide |
Depiction based on curated SMILES
O
Cl
NH
2
N
N
H
O
N
O
N
|
Brucella |
VirB type IV secretion system |
Preclinical (in vivo) |
Paschos A, et al. 2011. Infect Immun |
|
4-hydroxy-2-oxo-N,4-diphenylbut-3-enamide |
Depiction based on curated SMILES
O
N
H
O
OH
|
Brucella |
VirB type IV secretion system |
Preclinical (in vivo) |
Paschos A, et al. 2011. Infect Immun |
|
N-[[amino(pyridin-2-yl)methylidene]amino]-5-methyl-2-nitrobenzamide |
Depiction based on curated SMILES
N
H
N
NH
N
H
CH
3
O
_
O
O
+
N
|
Brucella |
VirB type IV secretion system |
Preclinical (in vivo) |
Paschos A, et al. 2011. Infect Immun |
|
UM0125848 (internal name in literature) |
Depiction based on curated SMILES
_
O
OH
OH
O
O
O
+
N
N
N
H
|
Brucella |
VirB type IV secretion system |
Preclinical (in vivo) |
Smith MA, et al. 2012. Chem Biol |
|
2-benzyl-8-cyclopropyl-7-(1-naphthylmethyl)-5-oxo-thiazolo[3,2-a]pyridine-3-carboxylic acid |
Depiction based on curated SMILES
O
N
OH
O
S
|
Escherichia |
Type 1 fimbriae; P fimbriae; S fimbriae |
Preclinical (in vivo) |
Greene SE, et al. 2014. mBio |
|
3-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]phenyl]-N-methylbenzamide |
Depiction based on curated SMILES
O
OH
OH
HO
HO
H
3
C
OH
H
O
NH
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
3-[4-[(R)-hydroxy-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-N-methylbenzamide |
Depiction based on curated SMILES
O
CH
3
HO
OH
OH
OH
CH
3
HO
H
O
N
H
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
3-[4-[(S)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]phenyl]-N-methylbenzamide |
Depiction based on curated SMILES
O
OH
HO
HO
OH
H
3
C
OH
O
N
H
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
| | |